DEVON LEWIS: Open Payments
NPI 1114507357 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 24 payments from 10 companies in 2025. Trend: 2023 $451 · 2024 $405 · 2025 $689
Food & beverage: $617Education: $71
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $189 |
| Vanda Pharmaceuticals Inc. | 3 | $164 |
| Almatica Pharma LLC | 4 | $69 |
| Alkermes, Inc. | 3 | $60 |
| Lundbeck LLC | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
Products named: FANAPT, AUSTEDO XR, LOREEV XR, ARISTADA, REXULTI, CAPLYTA, TRINTELLIX, UZEDY.
Industry payments across AZ — which companies pay providers there.
